Filter Applied: stimulant drugs (Click to remove)
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008
Treatment of Attention-Deficit-Hyperactivity Disorder
NEJM 340:780-788, Elia,J.,et al, 1999
Toxicity and Deaths from 3, 4-Methylenedioxymethamphetamine ("ecstast")
Lancet 340:384-387, Henry,J.A.,et al, 1992
"Bath Salts" Intoxication
NEJM 365:967-968, Ross, E.A.,et al, 2011
Narcolepsy With Cataplexy
Lancet 369:499-511, Dauvilliers,Y.,et al, 2007
ADHD Drugs and Cardiovascular Risk
NEJM 354:1445-1448, Nissen,S.E., 2006
Evidence Based Management of Attention Deficit Hyperactivity Disorder
BMJ 323:1232-1235, Guevara,J.P. &Stein,M.T., 2001
Treatment Modalities for Narcolepsy
Neurol 50:S43-S48, Fry,J.M., 1998
Attention-Deficit Hyperactivity Disorder and Hyperkinetic Disorder
Lancet 351:429-433, 3871998., Swanson,J.M.,et al, 1998
Medication for Children with Attentional Disorders
Pediatrics 98:301-304, Perrin,J.,et al, 1996
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
The Medical Letter, 36:109-1101994., , 1994
Psychotropic Drugs and Sleep
BMJ 306:1331-1334, Eisen,J.,et al, 1993
Side Effects of Methylphenidate in Children with Attention Deficit Hyperactivity Disorder
Pediatrics 86:184-192, Barkley,R.A.,et al, 1990
Depression of Growth in Hyperactive Children on Stimulant Drugs
NEJM 287:217, 1972; 287:249972., Safer,D.,et al, 1972